The National Pathology and Laboratory Round Table provides national leadership and independent advice to the Director-General of Health on clinical, scientific and strategic aspects of the Pathology and Laboratory sector.
These aspects include:
- using laboratory information to support the efficient planning and commissioning of health services for populations
- informing investment in new health technology and procedures
- the protection of society from harm associated with communicable diseases
- the early detection and screening of disease
- ensuring that systems, processes and practices are in place to provide assurance to the health service about the quality of laboratory and pathology services and information.
About pathology and laboratory services
Pathology and laboratory services are a critical, often invisible part of the patient’s clinical pathway.
Laboratory tests underpin disease screening for risk factors, determination of disease severity, recovery likelihood, therapeutic selection, monitoring and investigation of adverse outcomes.
At the population health level clinical laboratories are critical in the identification of hospital acquired infections, identifying antimicrobial resistance patterns, and in the control of infectious disease outbreaks and exposures to toxic substances.
Pathology and Laboratory services are involved at multiple stages of the patient pathway and cross community, primary, secondary and tertiary service boundaries. It is generally accepted that approximately 70% of diagnoses rely on output from Pathology or Laboratory services.
In 2009, a Ministerial Review Group (MRG) noted that service access for laboratory services was inconsistent both in terms of the range of services available and the cost of services to consumers. They recommended that the Ministry of Health review the arrangements for planning, funding and provision of national, regional and local laboratory services with a view to determining the optimal planning, funding, and service configuration arrangements for New Zealand. Download the MRG report from the Beehive website for more information.
In response to the MRG report, the Ministry convened the Round Table in 2010 with a view to strengthen engagements within the Laboratory and Pathology sector. The group was comprised of key sector leaders from DHBs, private and community laboratories and the Ministry. It is chaired by the Chief Medical Officer. The Round Table has continued to meet on a regular basis.
The Round Table is tasked with working collaboratively with the wider health sector stakeholders to achieve the objectives set out in the Strategic Framework.
- Develop a strategic framework and associated annual workplan that is adaptive and responsive to the changing needs of the health sector.
- Determine key priorities for the Round Table
- Support any subcommittees in implementation agreed recommendations resulting from the workplan
- Establish links across the sector and other agencies
- Appropriately guide the introduction and adoption of new technologies
- Monitor local and overseas developments related the Pathology and Laboratory sector and provide advice on the implications for New Zealand.
- Oversee the function of any subgroups established by the Round Table
- Respond to questions and requests from the Director General of Health.
- Make recommendations concerning the establishment of limited life subgroups to the Director General of Health.
Membership is made up of interested sector leaders, National Health Board staff and stakeholders from the Pathology and Laboratory sector.
Membership is for three years, with the option of reappointment after this time by the Director-General of Health through the Chair. The Director-General of Health may remove a member from office before the end of the term of appointment. Round Table members may also resign at any stage during their term by notice in writing to the Chair.
|Adri Isbister||Wairarapa DHB|
|Andrew Simpson||Ministry of Health (Chair)|
|Anja Werno||Canterbury DHB|
|Anna Kula||Ministry of Health (Secretariat)|
|Cam Kyle||LabPlus Auckland DHB|
|Cynric Temple-Camp||Medlab Central, NZ Society of Pathologists|
|Deborah Powell||Union (APEX)|
|Don Mikkelsen||Counties Manukau DHB|
|Gloria Crossley||Taranaki DHB|
|Kirsten Beynon||Canterbury DHB|
|Nicole Kramer||Royal Australasian College of Pathologists|
|Peter Gootjes||Southern Community Labs|
|Richard Massey||Pathology Associates|
|Ross Boswell||Royal Australasian College of Physicians|
|Ross Hewett||LabPlus Auckland DHB|
|Russell Cooke||Capital & Coast DHB|
|Ruth Rhodes||Waikato DHB|
|Sarah Prentice||Northern Region Alliance|
|Trevor English||Southern Community Labs|
Read the terms of reference here
Read the meeting minutes here
Read the strategic framework here